Boralex's stock price is now closely tied to Brookfield's proposed take-private offer of CA$37.25, with analysts adjusting their price targets accordingly. This alignment raises questions about the company's growth prospects post-transaction.
As Boralex moves closer to being taken private by Brookfield Renewables, its share price has stabilized around the proposed offer of CA$37.25. Analysts are responding with revised price targets, reflecting a cautious optimism about the deal while also highlighting potential limitations on future growth beyond the acquisition. With a fair value estimate of CA$36.88, the market is weighing the implications of this significant transaction for Canadian investors.
Investor takeaway: Long-term holders should consider how the Brookfield deal may reshape Boralex's growth trajectory and market positioning.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Brookfield Asset Management Ltd
BAM.TO
BAM.TO
Brookfield Asset Management Ltd
WealthAwesomeMarket cap
$108.28B
P/E
30.8x
Div. yield
2.70%
Div. / share
$1.81
52W high
$84.98
52W low
$57.50
1W change
+4.32%
Beta
1.26
Analyst Price Targets
Based on analyst covering BAM
Wall Street analysts forecast BAM stock price to rise 19.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$80.10
+19.2% Upside
Current Price
C$67.19
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BAM's historical volatility
30-Day Vol
27.4%
Annualized
90-Day Vol
27.6%
Annualized
Trend (90d)
+7.3%
Annualized drift
90d Mean
C$68.97
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$67.78 | C$61.66 – C$74.50 |
| 60 trading days | C$68.37 | C$59.81 – C$78.16 |
| 90 trading days | C$68.97 | C$58.54 – C$81.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
How the Proposed Acquisition Shapes Boralex's Valuation
Boralex's fair value estimate remains stable at CA$36.88, with revenue growth expectations at 4.98% and a net profit margin of 34.60%. This stability amidst the acquisition discussions suggests that while the deal is seen as a fair valuation, future growth may be constrained, impacting long-term investor sentiment.
Bull case
- Analysts from RBC Capital and Scotiabank are raising their price targets, showing confidence in the valuation implied by the Brookfield offer.
- The alignment of multiple firms around the CA$37.25 level indicates a consensus that the take-private transaction is a fair reflection of Boralex's value.
Bear case
- Raymond James has downgraded Boralex to Market Perform, indicating limited upside potential beyond the acquisition price.
- Concerns over execution and growth options after the transaction are leading some analysts to take a more cautious stance.
Analysts Weigh In on Boralex's Valuation
Advertisement
RBC Capital and Scotiabank's bullish outlook reflects confidence in the proposed acquisition's valuation, suggesting that the CA$37.25 offer by Brookfield is a reasonable anchor for Boralex's stock price. This alignment among analysts indicates a strong consensus on the stock's current value amidst the ongoing deal discussions.
Cautious Sentiment from Raymond James
Despite the bullish sentiment from some analysts, Raymond James has taken a more cautious approach, downgrading Boralex to Market Perform and setting a price target at CA$37.25. This move highlights concerns over the limited upside potential and questions about the company's growth trajectory following the acquisition.
The Future of Boralex Post-Acquisition
As the acquisition progresses, Boralex's future growth potential remains a key focus for investors. With a significant project pipeline and the growing demand for clean energy, the company may face challenges such as rising debt and competition for long-term contracts. Investors will need to monitor how these factors play out in the context of the Brookfield deal.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
